Company: SXTPW
Filing Date: 2025-08-15
Form Type: PRE 14A
Source: 0001213900-25-077435
Chunk: 94

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-08-15
Form: PRE 14A
Chunk 94
---
 holders
thereof, be combined and converted into one share of Common Stock without increasing or decreasing the par value of each share of Common
Stock (the “Reverse Stock Split”). No fractional shares of Common Stock shall be issued as a result of the Reverse
Stock Split and, in lieu thereof, upon surrender after the Effective Time of a certificate or book entry position which formerly represented
shares of Common Stock that were issued and outstanding immediately prior to the Effective Time, any person who would otherwise be entitled
to a fractional share of Common Stock as a result of the Reverse Stock Split, following the Effective Time, shall be entitled to receive
one whole share. The Reverse Stock Split shall occur whether or not the certificates representing such shares of Common Stock are surrendered
to the Corporation or its transfer agent. Each certificate or book entry position that immediately prior to the Effective Time represented
shares of Common Stock shall thereafter represent the number of shares of Common Stock into which the shares of Common Stock represented
by such certificate or book entry position has been combined, subject to the right to receive a whole share in lieu of any fractional
share of Common Stock as set forth above.”

SECOND: That thereafter, the
holders of outstanding stock having not less than the minimum number of votes that would be necessary to authorize or take such action
at a stockholders meeting at which all shares entitled to vote thereon were present and voted, approved of the proposed amendment at the
Annual Meeting of Stockholders held on July 16, 2024 pursuant to Section 242 of the General Corporation Law of the State of Delaware.

THIRD: That said amendment was
duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.

IN WITNESS WHEREOF, said corporation has
caused this certificate to be signed on [*], 2025.

| By:    |                                       |
| Name:  | Geoffrey Dow                          |
| Title: | Chief Executive Officer and President |

<div align='center'>C-1</div>

IN WITNESS WHEREOF, the parties
hereto have executed this Amendment as of the date first set forth above.

| COMPANY                           |
| 60 DEGREES PHARMACEUTICALS, INC., |
| a Delaware corporation            |
| By:                               |
| Name:                             |
| Title:                            |

| OPTIONHOLDER |
| Name:        |

<div align='center'>C-2</div>